mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0005 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.05 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |